In a filing, Vaxcyte Inc revealed its PRESIDENT AND CFO GUGGENHIME ANDREW unloaded Company’s shares for reported $0.69 million on Jan 21 ’25. In the deal valued at $86.51 per share,8,000 shares were sold. As a result of this transaction, GUGGENHIME ANDREW now holds 109,491 shares worth roughly $9.81 million.
Then, GUGGENHIME ANDREW bought 8,000 shares, generating $688,480 in total proceeds.
Before that, Loxam Teri sold 6,250 shares. Vaxcyte Inc shares valued at $531,963 were divested by the Director at a price of $85.11 per share. As a result of the transaction, Loxam Teri now holds 7,175 shares, worth roughly $0.64 million.
Goldman initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 20, 2024; the price target was $135. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. TD Cowen began covering PCVX with “an Outperform” recommendation on April 18, 2023. Needham maintained its rating on January 03, 2023. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Friday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock fall -0.37% to $89.64. Over the last five days, the stock has gained 2.06%. Vaxcyte Inc shares have risen nearly 9.50% since the year began. Nevertheless, the stocks have risen 37.67% over the past one year. While a 52-week high of $121.06 was reached on 01/24/25, a 52-week low of $58.10 was recorded on 01/14/25. SMA at 50 days reached $88.31, while 200 days put it at $86.52.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 88.35, which if violated will result in even more drops to 87.06. On the upside, there is a resistance level at 91.49. A further resistance level may holdings at 93.35. The Relative Strength Index (RSI) on the 14-day chart is 54.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.29, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 16.64%. Stochastics %K at 83.46% indicates the stock is a selling.
How much short interest is there in Vaxcyte Inc?
A steep rise in short interest was recorded in Vaxcyte Inc stocks on 2024-12-31, growing by 3.29 million shares to a total of 14.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 11.03 million shares. There was a rise of 22.97%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 15, 2022 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $66 price target.
